The Gut-Skin Connection: The Microbiome and Its Effects on the Skin


The Gut-Skin Connection: The Microbiome and Its Effects on the Skin

Release: 6/15/2021; Expiration: 6/15/2022

Activity Overview

There is no doubt that clinicians have been exposed to more information about the human gut than ever before, and most practitioners treating skin disorders have had some form of education related to the skin microbiome. However, the question remains as to how the gut microbiome affects the skin, and vice versa, the ways in which treatments for skin diseases affect the gut. How can this new focus and insight into the gut be applied to practice? During this engaging and interactive meeting, you will have a chance to hear from and interact with experts across specialties on what we know about the gut, how it relates to the skin and what we can do to enhance our patients’ outcomes.

The human gastrointestinal (GI) tract harbors approximately 500 different species of microorganisms that contribute to host homeostasis, allostasis, and pathogenesis of disease. Collectively referred to as the gut microbiota, the composition of these microorganisms can be heavily influenced by intake of prebiotics, probiotics, and synbiotics. Intentional modulation of the gut microbiome has proven beneficial in the prevention and/or treatment of inflammatory skin diseases including acne vulgaris, atopic dermatitis, and psoriasis. This presents a unique opportunity for physicians to exploit the complex immune mechanisms that extend from the gut microbiome to involve distant organ systems including the skin.

This program serves to introduce healthcare practitioners to the human gut microbiome and review the ways in which it can be modified to benefit gut and skin health. Participants will gain education that allows them to better understand the gut-skin axis and explore potential therapeutic options for harnessing the gut microbiome’s influence in the treatment of skin disease.

Target Audience

This activity is designed to meet the needs of physicians, nurses and professional staff members of medical practices.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Review the function of the gut and the nexus of the gut microbiome and the skin
  • Discuss the role of the gut microbiota in the pathogenesis of common skin disorders
  • Interpret the roles of testing, nutrition, probiotics/prebiotics, in addressing dysbiosis of the gut microbiota
  • Apply evidence-based interventions that affect the gut microbiome in order to better treat skin disorders

Criteria for Success

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at


Credit provided by AKH Inc., Advancing Knowledge in Healthcare

Jointly Accredited Provider

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 3 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.


3 ANCC contact hours

Commercial Support

There is no commercial support for this activity.


It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.





Whitney Bowe, MD


Nothing to disclose

Thomas Guilliams, PhD


Ortho Molecular Products

Todd LePine, MD

Scientific Advisory Board

Diagnostic Solutions Laboratory

Peter Lio, MD


Amirall, ASLAN Pharmaceuticals, UCB, Dermavant, Regeneron/Sanofi Genzyme, Pfizer, LEO Pharmaceuticals, AbbVie, Eli Lilly, Micreos, L'Oreal, Pierre-Fabre, Johnson & Johnson, Level Ex, Unilever, Menlo Therapeutics, Theraplex, IntraDerm, Exeltis, AOBiome, Realm Therapeutics, Altus Labs, Galderma, Verrica, Arbonne, Amyris, Bodewell, YobeeCare, Burt's Bees, My-Or Diagnostics, and Kimberly-Clark

Contracted Research

AbbVie, Regeneron/Sanofi, AOBiome


Theraplex AIM OTC moisturizer

Speakers Bureau

Regeneron/Sanofi Genzyme, Pfizer, LEO, Eli Lilly, Galderma, and L'Oreal


Altus Labs, Micreos, YoBee

Raja Sivamani, MD


Burt’s Bees, Novozymes, Nutrafol, Abbvie, Leo, UCB, Sun and Regeneron Pharmaceuticals

Scientific Advisor


Dorothy Caputo, MA, BSN, RN - CE Director of Accreditations


Nothing to disclose

LiVDerm Planners and Reviewers


Nothing to disclose

AKH Planners and Reviewers


Nothing to disclose

All of the relevant financial relationships listed for these individuals have been mitigated.


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Required hardware/software:

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

Call us to discuss which services would best fit your needs